GlassScriptPhysician profile
Alzora Williams Smith
NPI 1073604823
$1,619.53
in general payments reported to CMS, 2019-2025
17 companies · $263 in 2025
The $263 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $191 · 2022: $356 · 2023: $405 · 2024: $405 · 2025: $263.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,072.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,072.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $191.76 | 2021-2024 | |
| Novo Nordisk INC | $123.67 | 2022-2023 | Wegovy |
| Bayer Healthcare Pharmaceuticals INC. | $110.08 | 2023 | |
| Xeris Pharmaceuticals, INC. | $110.08 | 2022 | |
| Amgen INC. | $110.08 | 2022 | |
| Acadia Pharmaceuticals INC | $99.35 | 2024 | Nuplazid |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $98.04 | 2025 | Rexulti |
| Genzyme Corporation | $96.17 | 2023 | |
| Lilly USA, LLC | $95.05 | 2025 | Zepbound |
| Neurelis, INC. | $94.41 | 2024 | Valtoco |
| Genentech, INC. | $94.15 | 2023 | Xolair |
| Astrazeneca Pharmaceuticals LP | $87.72 | 2024 | Airsupra |
| Sanofi Pasteur INC. | $80.04 | 2021 | |
| Sanofi-Aventis U.S. LLC | $73.49 | 2022 | |
| Abbott Laboratories | $69.53 | 2025 | Freestyle Libre 3 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $43.46 | 2023 | |
| Genentech USA, INC. | $42.45 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alzora Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.